Clinical Trial Update: Rectal Indomethacin vs Intravenous Ketorolac [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing rectal indomethacin to intravenous ketorolac in patients with post-ERCP pancreatitis has completed and posted results. The study evalu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Pancreatitis

Drugs mentioned

• Ketorolac (intravenous) (ketorolac)
• Rectal Indomethacin (indomethacin)

Snippet

Sponsor: David Vitale MD | Conditions: Post-ERCP Acute Pancreatitis | Phase 4 | Status: COMPLETED | Results posted: 2026-03-12